Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients

NCT05447013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Severe COVID-19

Interventions

BIOLOGICAL: Coronavirus-2-specific T cells
OTHER: standard of care (SOC)

Sponsor

George Papanicolaou Hospital

Collaborators

[object Object]